Semler Scientific, Inc. (SMLR)
USD 33.51
(-1.63%)
USD 33.51
(-1.63%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 6.27 Million USD | -10.65% |
| 2022 | 7.01 Million USD | 36.92% |
| 2021 | 5.12 Million USD | 5.76% |
| 2020 | 4.84 Million USD | -7.06% |
| 2019 | 5.21 Million USD | 48.0% |
| 2018 | 3.52 Million USD | -48.35% |
| 2017 | 6.82 Million USD | 13.85% |
| 2016 | 5.99 Million USD | 44.33% |
| 2015 | 4.15 Million USD | 2.14% |
| 2014 | 4.06 Million USD | 101.29% |
| 2013 | 2.01 Million USD | -60.03% |
| 2012 | 5.05 Million USD | 341.91% |
| 2011 | 1.14 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 6.38 Million USD | 7.36% |
| 2024 Q1 | 5.95 Million USD | -5.1% |
| 2024 Q3 | 6.83 Million USD | 7.06% |
| 2023 FY | 6.27 Million USD | -10.65% |
| 2023 Q2 | 10.19 Million USD | 12.62% |
| 2023 Q3 | 8.67 Million USD | -14.99% |
| 2023 Q4 | 6.27 Million USD | -27.68% |
| 2023 Q1 | 9.05 Million USD | 29.06% |
| 2022 Q2 | 6.96 Million USD | 15.27% |
| 2022 Q1 | 6.04 Million USD | 17.91% |
| 2022 Q4 | 7.01 Million USD | -18.09% |
| 2022 FY | 7.01 Million USD | 36.92% |
| 2022 Q3 | 8.56 Million USD | 22.98% |
| 2021 Q3 | 6.95 Million USD | 12.59% |
| 2021 Q1 | 5.37 Million USD | 10.98% |
| 2021 FY | 5.12 Million USD | 5.76% |
| 2021 Q2 | 6.18 Million USD | 14.93% |
| 2021 Q4 | 5.12 Million USD | -26.35% |
| 2020 Q4 | 4.84 Million USD | -19.18% |
| 2020 FY | 4.84 Million USD | -7.06% |
| 2020 Q1 | 3.82 Million USD | -26.74% |
| 2020 Q2 | 4.36 Million USD | 14.35% |
| 2020 Q3 | 5.99 Million USD | 37.27% |
| 2019 FY | 5.21 Million USD | 48.0% |
| 2019 Q1 | 2.89 Million USD | -17.85% |
| 2019 Q2 | 3.6 Million USD | 24.5% |
| 2019 Q3 | 4.75 Million USD | 31.97% |
| 2019 Q4 | 5.21 Million USD | 9.65% |
| 2018 Q4 | 3.52 Million USD | -25.53% |
| 2018 Q1 | 5.78 Million USD | -15.25% |
| 2018 Q2 | 5.09 Million USD | -11.85% |
| 2018 Q3 | 4.73 Million USD | -7.16% |
| 2018 FY | 3.52 Million USD | -48.35% |
| 2017 Q3 | 7.45 Million USD | 9.85% |
| 2017 Q1 | 6.35 Million USD | 6.06% |
| 2017 FY | 6.82 Million USD | 13.85% |
| 2017 Q4 | 6.82 Million USD | -8.55% |
| 2017 Q2 | 6.79 Million USD | 6.86% |
| 2016 Q2 | 5.59 Million USD | 9.95% |
| 2016 FY | 5.99 Million USD | 44.33% |
| 2016 Q4 | 5.99 Million USD | 3.9% |
| 2016 Q1 | 5.08 Million USD | 22.52% |
| 2016 Q3 | 5.76 Million USD | 3.11% |
| 2015 FY | 4.15 Million USD | 2.14% |
| 2015 Q4 | 4.15 Million USD | 38.88% |
| 2015 Q3 | 2.98 Million USD | -24.9% |
| 2015 Q2 | 3.98 Million USD | 4.52% |
| 2015 Q1 | 3.8 Million USD | -6.3% |
| 2014 Q4 | 4.06 Million USD | 55.89% |
| 2014 Q2 | 1.74 Million USD | -2.89% |
| 2014 Q3 | 2.6 Million USD | 49.06% |
| 2014 FY | 4.06 Million USD | 101.29% |
| 2014 Q1 | 1.8 Million USD | -10.8% |
| 2013 FY | 2.01 Million USD | -60.03% |
| 2013 Q2 | 2.11 Million USD | -66.98% |
| 2013 Q3 | 1.96 Million USD | -7.14% |
| 2013 Q4 | 2.01 Million USD | 2.85% |
| 2013 Q1 | 6.4 Million USD | 26.77% |
| 2012 Q4 | 5.05 Million USD | 0.0% |
| 2012 FY | 5.05 Million USD | 341.91% |
| 2011 FY | 1.14 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 87.767% |
| BrainsWay Ltd. | 15.31 Million USD | 59.057% |
| Cerus Corporation | 144.3 Million USD | 95.655% |
| Envoy Medical, Inc. | 9.4 Million USD | 33.312% |
| electroCore, Inc. | 8.94 Million USD | 29.905% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -17.372% |
| IceCure Medical Ltd | 4.24 Million USD | -47.634% |
| Inogen, Inc. | 121.38 Million USD | 94.834% |
| OrthoPediatrics Corp. | 72.56 Million USD | 91.359% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 78.804% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -97.049% |
| MaxCyte, Inc. | 36.1 Million USD | 82.635% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -239.302% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -1374.319% |
| Orthofix Medical Inc. | 326.58 Million USD | 98.08% |
| PAVmed Inc | 57.13 Million USD | 89.026% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | 75.376% |
| RxSight, Inc. | 22.18 Million USD | 71.741% |
| Sight Sciences, Inc. | 46.43 Million USD | 86.498% |
| SI-BONE, Inc. | 61.05 Million USD | 89.73% |
| TELA Bio, Inc. | 59.16 Million USD | 89.403% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 94.499% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | 39.238% |
| Acutus Medical, Inc. | 54.83 Million USD | 88.567% |
| Talis Biomedical Corporation | 29.22 Million USD | 78.545% |
| Spectral AI, Inc. | 12.4 Million USD | 49.44% |
| Nano-X Imaging Ltd. | 23.13 Million USD | 72.897% |
| CVRx, Inc. | 39.28 Million USD | 84.038% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | 47.567% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -158.099% |
| Bioventus Inc. | 589.79 Million USD | 98.937% |
| Venus Concept Inc. | 107.1 Million USD | 94.146% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 87.864% |
| LivaNova PLC | 1.15 Billion USD | 99.456% |
| 908 Devices Inc. | 37.49 Million USD | 83.276% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 99.109% |
| Nemaura Medical Inc. | 26.37 Million USD | 76.23% |
| NeuroPace, Inc. | 86.99 Million USD | 92.793% |
| LENSAR, Inc. | 22.4 Million USD | 72.02% |
| Apyx Medical Corporation | 52.31 Million USD | 88.016% |
| Cutera, Inc. | 518.12 Million USD | 98.79% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | 78.621% |
| BioSig Technologies, Inc. | 4.68 Million USD | -33.831% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 89.258% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | 70.821% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 99.714% |
| Axonics, Inc. | 82.35 Million USD | 92.387% |
| Outset Medical, Inc. | 190.91 Million USD | 96.716% |
| IRIDEX Corporation | 24.91 Million USD | 74.833% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 94.942% |
| IRadimed Corporation | 20.73 Million USD | 69.763% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -274.552% |
| INVO Bioscience, Inc. | 19.99 Million USD | 68.642% |
| Telesis Bio, Inc. | 40.87 Million USD | 84.66% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 84.629% |
| Varex Imaging Corporation | 668.6 Million USD | 99.062% |
| Quipt Home Medical Corp. | 136.29 Million USD | 95.4% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -75.532% |
| Pulmonx Corporation | 60.63 Million USD | 89.66% |
| Dynatronics Corporation | 11.78 Million USD | 46.775% |
| Modular Medical, Inc. | 2.27 Million USD | -175.968% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -54.281% |
| InMode Ltd. | 75.91 Million USD | 91.741% |
| Bruker Corporation | 2.83 Billion USD | 99.779% |
| Cytosorbents Corporation | 29.98 Million USD | 79.09% |
| DexCom, Inc. | 4.19 Billion USD | 99.851% |
| Align Technology, Inc. | 2.45 Billion USD | 99.744% |
| Viveve Medical, Inc. | 10.84 Million USD | 42.196% |
| ZimVie Inc. | 795.85 Million USD | 99.212% |
| Movano Inc. | 5.97 Million USD | -4.99% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 94.006% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -1374.319% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | 47.567% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 99.019% |
| Profound Medical Corp. | 12.66 Million USD | 50.497% |
| Insulet Corporation | 1.85 Billion USD | 99.662% |
| enVVeno Medical Corporation | 2.43 Million USD | -157.495% |
| Surmodics, Inc. | 65.82 Million USD | 90.474% |
| iCAD, Inc. | 8 Million USD | 21.635% |
| Nuwellis, Inc. | 6.78 Million USD | 7.522% |
| Biotricity, Inc. | 35.91 Million USD | 82.544% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 97.189% |
| Aethlon Medical, Inc. | 2.47 Million USD | -152.858% |
| InspireMD, Inc. | 8.14 Million USD | 22.992% |
| PAVmed Inc. | 57.13 Million USD | 89.026% |
| BIOLASE, Inc. | 35.34 Million USD | 82.262% |
| Beyond Air, Inc. | 29.77 Million USD | 78.942% |
| FONAR Corporation | 57.45 Million USD | 89.088% |
| AxoGen, Inc. | 101.16 Million USD | 93.802% |
| Vivani Medical, Inc. | 25.03 Million USD | 74.956% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 92.858% |
| Inari Medical, Inc. | 209.32 Million USD | 97.005% |
| UFP Technologies, Inc. | 118.04 Million USD | 94.688% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | 50.593% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -186.85% |
| Tenon Medical, Inc. | 5.56 Million USD | -12.628% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -252.445% |
| Co-Diagnostics, Inc. | 17.63 Million USD | 64.444% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.801% |
| Sintx Technologies, Inc. | 6.59 Million USD | 4.899% |
| NanoVibronix, Inc. | 2.68 Million USD | -133.433% |
| Quanterix Corporation | 78.08 Million USD | 91.97% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -75.532% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -28.352% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 99.4% |
| TransMedics Group, Inc. | 568.84 Million USD | 98.898% |
| ReWalk Robotics Ltd. | 16.68 Million USD | 62.415% |
| NeuroMetrix, Inc. | 1.33 Million USD | -370.324% |
| Hyperfine, Inc. | 9.8 Million USD | 36.02% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 97.494% |
| Biomerica, Inc. | 2.66 Million USD | -135.449% |
| Bone Biologics Corporation | 831.4 Thousand USD | -654.148% |
| AVITA Medical, Inc. | 19.86 Million USD | 68.438% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -217.68% |
| Silk Road Medical, Inc | 114.15 Million USD | 94.508% |